Preoperative ROS1-TKI Therapy for ROS1 Fusion-Positive Locally Advanced Lung Adenocarcinoma
NCT07700836
·
clinicaltrials.gov ↗
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
ROS1 Fusion-Positive Lung Adenocarcinoma
Interventions
DRUG:
ROS1-TKI Therapy
Sponsor
Peking University Cancer Hospital & Institute